Press release
Omeprazole Market Size, Share, Growth, Trends And Forecast 2024-2033
The new report published by The Business Research Company, titled Omeprazole Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.As per the report, the omeprazole market size has grown strongly in recent years. It will grow from $2.17 billion in 2023 to $2.34 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The omeprazole market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16495&type=smp
Impact Of Rising Gastric Cancer Incidence On The Growth Of The Omeprazole Market
The increased incidence of gastric cancers is expected to propel the growth of the omeprazole market going forward. Gastric cancers refer to malignancies that originate in the lining of the stomach. The increased incidence of gastric cancers is due to chronic helicobacter pylori infection, heavy alcohol consumption, genetic predisposition, chronic gastritis, obesity, and geographical variations in prevalence. Omeprazole, a proton pump inhibitor, helps manage gastric cancers by reducing stomach acid production, which can alleviate symptoms, improve quality of life, and support healing ulcers or lesions in the stomach lining. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, gastrointestinal cancers increased by 3.18% to 348,840 compared to 338,090 in 2021 in the United States. Therefore, the increased incidence of gastric cancers is driving the omeprazole market.
Advancements In Omeprazole Formulations
Major companies operating in the omeprazole market are developing ready-to-use liquid formulations to enhance patient convenience and compliance, particularly for those who have difficulty swallowing tablets or capsules. Ready-to-use liquid formulations of omeprazole help to improve patient compliance, enhance convenience, provide accurate dosing, offer a faster onset of action, and ensure enhanced medication stability. For instance, in February 2024, Alkaloid AD, a North Macedonia-based pharmaceutical manufacturing company, launched liquid Omeprazole. It is the first ready-to-use liquid Omeprazole for reflux esophagitis and GERD patients unable to swallow tablets, and it features a dual-chamber package. This innovation provides a more practical and accessible treatment option for patients who have difficulty in swallowing tablets or capsules, such as young children, adult patients with dysphagia, and those with gastric feeding tubes or geriatric patients. The company has obtained the first international patent for a value-added medicine (VAM) for this product and has received marketing authorizations for the Macedonian and UK markets.
The omeprazole market covered in this report is segmented -
1) By Dosage Form: Capsule, Powder, Tablet
2) By Indication: Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16495&type=discount
Major companies operating in the omeprazole market are Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Fresenius Kabi, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited
Contents of the report:
1. Executive Summary
2. Omeprazole Market Report Structure
3. Omeprazole Market Trends And Strategies
4. Omeprazole Market - Macro Economic Scenario
5. Omeprazole Market Size And Growth
…..
27. Omeprazole Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Omeprazole Market Size, Share, Growth, Trends And Forecast 2024-2033 here
News-ID: 3619650 • Views: …
More Releases from The Business Research Company

C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…

Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…

2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…

2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Omeprazole
Evolving Market Trends In The Omeprazole Industry: Advancements In Omeprazole Fo …
The Omeprazole Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Omeprazole Market Size During the Forecast Period?
The omeprazole market has seen considerable growth in recent years. It is projected to rise from $2.34 billion in 2024 to $2.52 billion in 2025,…
Prominent Omeprazole Market Trend for 2025: Advancements In Omeprazole Formulati …
What combination of drivers is leading to accelerated growth in the omeprazole market?
The rising incidence of gastric cancers is expected to contribute to the growth of the omeprazole market. Gastric cancers are typically linked to factors like Helicobacter pylori infection and lifestyle habits. Omeprazole, a medication that reduces stomach acid production, helps alleviate symptoms and promote healing. In January 2023, the American Cancer Society reported a 3.18% increase in gastrointestinal…
What's Driving the Omeprazole Market 2025-2034: Impact Of Rising Gastric Cancer …
What Are the Projections for the Size and Growth Rate of the Omeprazole Market?
The market size for omeprazole has seen significant expansion in the past years. Its value is expected to increase from $2.34 billion in 2024 to $2.52 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. The surge in growth during the historic period can be traced back to factors such as recompense regulations, a…
Omeprazole Market Size, Share, Growth, Trends, Analysis and Forecast - 2028
The global omeprazole market is anticipated to grow at a CAGR of 5.1% during the forecast period (2022-2028).
Omeprazole, is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. Omeprazole is a medicine that can be used alone or in conjunction with other medications. It is used to treat GERD, ulcers, and other disorders brought on by too much stomach acid. The market is…
Omeprazole Market - Increasing prevalence of peptic ulcers is expected to propel …
The report presents an in-depth assessment of the Omeprazole Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the…
Proton Pump Inhibitors (PPIs) Market 2017 - Pantoprazole, Omeprazole, Lansoprazo …
Worldwide Proton Pump Inhibitors (PPIs) Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Proton Pump Inhibitors (PPIs) piece of the overall industry and Growth patterns, concentrating on driving Proton Pump Inhibitors (PPIs) industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022.
Get Free Sample Copy of Report Here: https://goo.gl/ydpu7k
Top Manufacturers Analysis of This Report
AstraZeneca,
Pfizer,
Janssen,
Eisai,
Eli Lilly,
Cadila Pharmaceuticals,
Santarus,…